Literature DB >> 17131623

Tumor markers in detection of lung cancer.

Joachim Schneider1.   

Abstract

The expression of biomarkers by lung cancers is useful in the diagnosis and clinical management of patients with lung cancer. Biomarkers provide insight into histogenesis, interrelationships, and biological behavior of lung tumors. This chapter presents data on lung cancer detection, involving some of the most studied and interesting lung cancer biomarkers to date-CYFRA 21-1, NSE, ProGRP, SCC, CEA, Tumor M2-PK, as well as markers in clinical application such as CRP, LDH, tumor-suppressor genes and oncogenes, CA125, CgA, NCAM, and TPA. Biomarker profiles in combination with fuzzy logic techniques have also been addressed. Serum markers used alone or in combination with other indices might play an important role in monitoring response to therapy in early detection of tumor reactivation in new treatment strategies as well as in secondary prevention.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17131623     DOI： 10.1016/s0065-2423(06)42001-1

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


  42 in total

1.  A comparative protein analysis of lung cancer, along with three controls using a multidimensional proteomic approach.

Authors:  Mahwish Saleem; Syed K Raza; Syed G Musharraf
Journal:  Exp Biol Med (Maywood)       Date:  2019-01

2.  Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.

Authors:  Chia-Cheng Tseng; Chin-Chou Wang; Chang-Chun Hsiao; Hung-I Lu; Steve Leu; Huang-Chih Chang; Kuo-Tung Huang; Wen-Feng Fang; Yu-Mu Chen; Shih-Feng Liu; Cheng-Ta Yang; Meng-Chih Lin; Hon-Kan Yip
Journal:  Tumour Biol       Date:  2016-04-08

3.  Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer.

Authors:  He-Guo Jiang; Jian Li; Shun-Bing Shi; Ping Chen; Li-Ping Ge; Qian Jiang; Xin-Ping Tang
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

4.  Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease.

Authors:  Feng Chen; Xiu-Ying Wang; Xiao-Hong Han; Hai Wang; Jun Qi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat.

Authors:  Xiaoli Hu; Qingzhao Li; Shifeng Shao; Qiang Zeng; Shoufang Jiang; Qi Wu; Chunyang Jiang
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-28       Impact factor: 4.223

6.  Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium.

Authors:  Gereon Poschmann; Barbara Sitek; Bence Sipos; Anna Ulrich; Sebastian Wiese; Christian Stephan; Bettina Warscheid; Günter Klöppel; Ann Vander Borght; Frans C S Ramaekers; Helmut E Meyer; Kai Stühler
Journal:  Mol Cell Proteomics       Date:  2009-01-27       Impact factor: 5.911

Review 7.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

8.  Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.

Authors:  Hongmei Ding; Jianhua Liu; Rong Xue; Peng Zhao; Yi Qin; Fang Zheng; Xuguo Sun
Journal:  Biomed Rep       Date:  2014-07-11

9.  Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis.

Authors:  Seung-Hun Shin; Ho-Shik Kim; Seung-Hyun Jung; Hai-Dong Xu; Yong-Bok Jeong; Yeun-Jun Chung
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

10.  Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Biomark Insights       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.